Table 1.
Clinical characteristics of ESRD patients underwent CAPD.
| Items | Patients (N = 196) |
| Age (years), mean ± SD | 56.1 ± 11.4 |
| Gender, No. (%) | |
| Female | 56 (28.6) |
| Male | 140 (71.4) |
| BMI (kg/m2), mean ± SD | 22.5 ± 2.9 |
| Current smoking, No. (%) | 42 (21.4) |
| Current drinking, No. (%) | 16 (8.2) |
| PDD (months), median (IQR) | 62.0 (49.3–79.0) |
| Kt/V, mean ± SD | 1.9 ± 0.4 |
| HB (g/L), mean ± SD | 101.8 ± 15.0 |
| WBC (×109/L), mean ± SD | 8.1 ± 2.3 |
| PLT (×109/L), mean ± SD | 204.9 ± 53.8 |
| CRP (mg/L), median (IQR) | 4.7 (2.9–7.7) |
| Scr (μmol/L), median (IQR) | 900.4 (770.2–1103.7) |
| SUA (μmol/L), median (IQR) | 411.4 (356.0–462.8) |
| Ca (mmol/L), median (IQR) | 2.2 (2.0–2.4) |
| Phosphorus (mmol/L), mean ± SD | 1.6 ± 0.4 |
| FBG (mmol/L), median (IQR) | 5.7 (4.5–6.9) |
| ALB (g/L), mean ± SD | 38.5 ± 6.2 |
| SBP (mm Hg), median (IQR) | 139.0 (128.0–152.0) |
| DBP (mm Hg), median (IQR) | 88.0 (82.0–93.0) |
| TG (mmol/L), median (IQR) | 1.5 (1.0–2.4) |
| TC (mmol/L), median (IQR) | 4.6 (3.9–5.5) |
| LDL-C (mmol/L), mean ± SD | 2.7 ± 0.7 |
| HDL-C (mmol/L), median (IQR) | 1.0 (0.8–1.2) |
ALB = albumin, BMI = body mass index, Ca = calcium, CAPD = continuous ambulatory peritoneal dialysis, CRP = C-reactive protein, DBP = diastolic blood pressure, ESRD = end-stage renal disease, FBG = fasting blood glucose, HB = hemoglobin, HDL-C = high density lipoprotein cholesterol, IQR = interquartile range, Kt/V = calculated as clearance (K) multiplied by treatment time (t) and divided by the urea distribution volume (V), LDL-C = low density lipoprotein cholesterol, PDD = peritoneal dialysis duration, PLT = platelet, SBP = systolic pressure, Scr = serum creatinine, SD = standard deviation, SUA = serum uric acid, TC = total cholesterol, TG = triglyceride, WBC = white blood cell.